Abstract: A two-stage, very fast symbol string matching mechanism measures the similarity of content between data sources, allowing for efficient detection and evaluation of exact as well as inexact matches. The disclosed approach pairs complementary encoding technique comprising a first fast lookup that identifies regions of possible similarity, and a second, more computationally intensive analysis that evaluates metrics of similarity and delimits copy boundaries. The original content remains private (encrypted) during processing.

Abstract: A two-stage, very fast symbol string matching mechanism measures the similarity of content between data sources, allowing for efficient detection and evaluation of exact as well as inexact matches. The disclosed approach pairs complementary encoding technique comprising a first fast lookup that identifies regions of possible similarity, and a second, more computationally intensive analysis that evaluates metrics of similarity and delimits copy boundaries. The original content remains private (encrypted) during processing.

Abstract: A two-stage, very fast symbol string matching mechanism measures the similarity of content between data sources, allowing for efficient detection and evaluation of exact as well as inexact matches. The disclosed approach pairs complementary encoding technique comprising a first fast lookup that identifies regions of possible similarity, and a second, more computationally intensive analysis that evaluates metrics of similarity and delimits copy boundaries. The original content remains private (encrypted) during processing.

Abstract: A two-stage, very fast symbol string matching mechanism measures the similarity of content between data sources, allowing for efficient detection and evaluation of exact as well as inexact matches. The disclosed approach pairs complementary encoding technique comprising a first fast lookup that identifies regions of possible similarity, and a second, more computationally intensive analysis that evaluates metrics of similarity and delimits copy boundaries. The original content remains private (encrypted) during processing.

Abstract: There is provided a compound of formula I wherein Z is selected from N and CR22, wherein R22 is H or a bond with D; wherein D is selected from a bond, C?O, and linear or branched hydrocarbon groups having a carbon chain of from 1 to 6 carbon atoms, wherein the carbon chain optionally contains an oxy group (?O), an ether (—O—) or thioether (—S—) link, wherein R1 is selected from: triazolyl, imidazolyl, pyrimidinyl radical wherein each of R2 to R6 is independently selected from —H, NO2, halo, —CN, —N[(C?O)0-1R12][(C?O)0-1R13] and —(CH2)0-1R14, or two adjacent groups of R2 to R6, together with the carbon atoms to which they are attached, form a ring, wherein at least one of R2 to R6 is —CN, wherein (i) at least one of R2 to R6 is —(CH2)0-1R14, or (ii) at least one of R2 to R6 is —N[(C?O)0-1R12][(C?O)0-1R13], or (iii) at least two adjacent groups of R2 to R6 together with the carbon atoms to which they are attached, form a ring, or (iv) at least one of R2 to R6 is —(CH2)0-1—O—R?14, wherein R12 and R13

Abstract: There is provided a compound of formula I wherein Z is selected from N and CR22, wherein R22 is H or a bond with D; wherein D is selected from a bond, C?O, and linear or branched hydrocarbon groups having a carbon chain of from 1 to 6 carbon atoms, wherein the carbon chain optionally contains an oxy group (?O), an ether (—O—) or thioether (—S—) link, wherein R1 is selected from: triazolyl, imidazolyl, pyrimidinyl radical wherein each of R2 to R6 is independently selected from —H, NO2, halo, —CN, —N[(C?O)0-1R12][(C?O)0-1R13] and —(CH2)0-1R14, or two adjacent groups of R2 to R6, together with the carbon atoms to which they are attached, form a ring, wherein at least one of R2 to R6 is —CN, wherein (i) at least one of R2 to R6 is —(CH2)0-1R14, or (ii) at least one of R2 to R6 is —N[(C?O)0-1R12][(C?O)0-1R13], or (iii) at least two adjacent groups of R2 to R6 together with the carbon atoms to which they are attached, form a ring, or (iv) at least one of R2 to R6 is —(CH2)0-1—O—R?14, wherein R12 and R13

Abstract: The present invention relates to steroid sulphatase and/or aromatase inhibitors of Formula III or Formula IV, wherein A is selected from H, OH, halogen and hydrocarbyl; D, E and F are each independently of each other an optional linker group; P, Q and R are independently of each other a ring system, wherein R4 and R5 are independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyl or cycloalkyl or alkenyl or optionally contain one or more hetero atoms or groups, and which can be used in medicine.